A share price of Aadi Bioscience Inc [AADI] is currently trading at $3.39, up 46.12%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The AADI shares have gain 40.66% over the last week, with a monthly amount glided 52.70%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Aadi Bioscience Inc [NASDAQ: AADI] stock has seen the most recent analyst activity on August 27, 2024, when Piper Sandler downgraded its rating to a Neutral and also revised its price target to $1.75 from $5. Previously, TD Cowen downgraded its rating to Hold on August 21, 2024. On August 21, 2024, downgrade downgraded it’s rating to Hold and revised its price target to $1.50 on the stock. H.C. Wainwright downgraded its rating to a Neutral. Jefferies initiated its recommendation with a Buy and recommended $45 as its price target on January 11, 2022. In a note dated September 14, 2021, Ladenburg Thalmann initiated an Buy rating and provided a target price of $51 on this stock.
Aadi Bioscience Inc experienced fluctuations in its stock price throughout the past year between $1.21 and $2.63. Currently, Wall Street analysts expect the stock to reach $1.63 within the next 12 months. Aadi Bioscience Inc [NASDAQ: AADI] shares were valued at $3.39 at the most recent close of the market. An investor can expect a potential drop of -51.92% based on the average AADI price forecast.
Analyzing the AADI fundamentals
Trailing Twelve Months sales for Aadi Bioscience Inc [NASDAQ:AADI] were 25.07M which represents 21.03% growth. Gross Profit Margin for this corporation currently stands at 0.87% with Operating Profit Margin at -2.64%, Pretax Profit Margin comes in at -2.46%, and Net Profit Margin reading is -2.46%. To continue investigating profitability, this company’s Return on Assets is posted at -0.72, Equity is -0.72 and Total Capital is -0.95.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.44 points at the first support level, and at 1.49 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.97, and for the 2nd resistance point, it is at 4.55.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Aadi Bioscience Inc [NASDAQ:AADI] is 4.89. In addition, the Quick Ratio stands at 4.54 and the Cash Ratio stands at 1.93. Considering the valuation of this stock, the price to sales ratio is 4.87, the price to book ratio is 1.21.
Transactions by insiders
Recent insider trading involved Lennon David James, CHIEF EXECUTIVE OFFICER, that happened on Oct 03 ’24 when 9689.0 shares were sold. Officer, Lennon David James completed a deal on Oct 03 ’24 to buy 9689.0 shares. Meanwhile, EXECUTIVE CHAIRMAN Desai Neil sold 40000.0 shares on Sep 03 ’24.
